pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
COMPANY OVERVIEW
Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
LOCATION
Stockholm, , Sweden
THERAPEUTIC AREAS
Hematology
WEBSITE
https://www.modustx.com/
CAREER WEBSITE
https://www.modustx.com/contact/careers/
SOCIAL MEDIA
INVESTORS
PRESS RELEASES
Sep 27, 2022
Karolinska Development’s portfolio company Modus Therapeutics has completed recruitment in a clinical phase 1b study of sevuparin
Sep 27, 2022
Karolinska Developments portföljbolag Modus Therapeutics har slutfört rekryteringen till en klinisk fas 1b-studie med sevuparin
Sep 2, 2022
Karolinska Development’s portfolio company Modus Therapeutics initiates inclusion in phase 1 study of sevuparin in pediatric patients with severe malaria
Dec 1, 2021
Karolinska Development’s portfolio company Modus Therapeutics initiates Phase 1b trial of its drug candidate sevuparin
Jul 15, 2021
Karolinska Developments portföljbolag Modus Therapeutics tillförs SEK 33 miljoner efter en övertecknad emission och förbereder nu inför börsnotering
For More Press Releases